Amyotrophic lateral sclerosis (ALS) and other motor neuron diseases (MNDs) are major global causes of death. However, their global incidence ...

Motor neuron diseases, such as amyotrophic lateral sclerosis (ALS) and hereditary spastic paraplegia (HSP), share physical similarities but have been largely viewed as genetically distinct. However, ...

Researchers in Australia have identified a three-drug combination that greatly extends the survival of motor neuron cells in ...

Scientists have discovered new genes behind Lou Gehrig's disease, bringing them one step closer to understanding the cause of the condition and several other devastating motor neuron diseases. Lou ...

The 2025 Research Innovation Grants are supporting projects focused on biomarkers, risk factors, and treatments for ALS.

Primary lateral sclerosis (PLS) and amyotrophic lateral sclerosis (ALS) are neurodegenerative diseases. PLS typically develops slowly, while ALS rapidly affects mobility and can become fatal.

A lack of palliative care provision for people with motor neurone disease (MND) following diagnosis can cause emotional distress and, in extreme cases, lead to people experiencing suicidal thoughts, ...

Results from a randomized clinical trial have shown that a potential new treatment can help control the immune response of patients with motor neuron disease (MND), which could reduce further damage ...

A new medicine, discovered by scientists, protects nerve cells damaged by motor neurone disease (MND), offering hope of substantially slowing the progression of "one of the cruellest diseases".

The experimental therapy M102 slowed disease progression in preclinical experiments done in mouse and cell models of ALS, a ...